well the simple truth is - it is difficult to sell and displace exisiting methods. Even if the products are sound and better, re-educating surgeons take years and years. And then there is the fact that the time period to see product effectiveness takes a good 18 - 24 months. So from early orders to seeing benefit to re-orders takes a good 2 - 3 years.
More staff means more cash burn, they need to manage with exisiting strength for now. Different conversation once they reach break even.
I like many here am frustrated too, but this is the reality of the challenging biotech sector.
well the simple truth is - it is difficult to sell and displace...
Add OSX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.9¢ |
Change
-0.001(1.43%) |
Mkt cap ! $7.559M | |||
| Open | High | Low | Value | Volume |
| 6.9¢ | 7.0¢ | 6.8¢ | $159.7K | 2.306M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8582 | 6.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.0¢ | 14200 | 1 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.9¢ |
Change
-0.001 ( 1.43 %) |
||||
| Open | High | Low | Volume | ||
| 6.9¢ | 7.0¢ | 6.9¢ | 206338 | ||
| Last updated 15.48pm 24/05/2024 ? | |||||
| OSX (ASX) Chart |